News & Articles

Sensyne and OMNY will collaborate on proposals to healthcare providers to use real-world data and advanced analytical tools to improve patient outcomes and accelerate the development of new medicines

Studying these organoids could help researchers develop and test new treatments for pancreatic cancer, one of the deadliest types of cancer.

The integrated calibration tools facilitate multi-parameter calibration across all lab systems

Queen's University experts say Computer hardware needs to be transformed to become more like the human brain if we are to lower greenhouse gas emissions

Leftover pulp from grapes can be a nutritious powerhouse – possibly reducing risk from illness such cardiovascular disease and diabetes

The findings will allow manufacturers to identify whether their juices contain A. suci, which leads to spoilage

Compared to conventional bandages, the organo-hydrogel bandages keep wounded areas moist and cool leading to accelerated healing

This research will advance the utilization of wastes generated in agricultural systems for value-added carbon production and ultimately energy storage devices

Teams uses mathematical modelling study to guide preparations for future health strategies

A first of its kind study demonstrates voltage outside of biological cells, with potential implications for cardiovascular disease, cancer and fertility treatment

Join leading researchers online to explore the latest advances and common challenges in the field of breath biopsy

Awarded jointly to Benjamin List and David W.C. MacMillan "for the development of asymmetric organocatalysis"

New life sciences brand enables breakthroughs to market with a fully integrated portfolio which promises unparalleled sample exploration and management solutions

This new oncology service supports unique in vitro investigations into the PK/PD relationship

Syukuro Manabe, Klaus Hasselmann and Giorgio Parisi honored for their groundbreaking contributions to our understanding of complex physical systems

Imperial College London has launched a pioneering new Institute to tackle some of the biggest challenges in infectious disease.

Guest blog by PromoCell explores if HLA-type could be a key differentiator in disease outcomes, and in developing treatments

Advance your biopharma research through HPLC with this first-of-its-kind application-focused resource